Product image of Fibryga (Human Fibrinogen) supplied by GNH India

Fibryga

Active Ingredient:
Human Fibrinogen
Origin:
EU

Fibryga (Human Fibrinogen)

Fibryga is a human fibrinogen concentrate used for intravenous administration. It is designed to help manage conditions related to fibrinogen deficiency, providing essential clotting factors for effective hemostasis.

Manufacturer / TM Owner

Octapharma S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Fibryga is primarily used to treat bleeding episodes in patients with congenital fibrinogen deficiency. This condition can lead to prolonged bleeding and difficulty in clotting blood. Fibryga provides the necessary fibrinogen to support normal clotting processes, helping to control bleeding episodes effectively. It is also used in surgical settings to prevent excessive blood loss during procedures.

Side Effects

  • When administered intravenously, Fibryga works by replenishing fibrinogen levels in the blood. This helps to form stable blood clots, reducing the risk of prolonged bleeding. Patients may experience improved clotting ability shortly after administration, which can be crucial in managing acute bleeding episodes or during surgical interventions.

Precautions & Warnings

  • Fibryga should be used under the supervision of a healthcare professional. Patients with a history of allergic reactions to fibrinogen or any of its components should exercise caution. It is important to monitor for signs of adverse reactions, such as allergic responses or thrombotic events, and to follow proper handling and storage guidelines to ensure safety and efficacy.

Avoid Interactions

  • Fibryga may interact with other medications that affect blood clotting. Patients taking anticoagulants or antiplatelet drugs should inform their healthcare provider before using Fibryga. Additionally, it is important to avoid using Fibryga with other blood products that may contain fibrinogen to prevent potential interactions and ensure optimal therapeutic effects.

Frequently Asked Questions

Fibryga is used to manage bleeding episodes in patients with congenital fibrinogen deficiency. It helps to replenish fibrinogen levels, supporting normal clotting processes.

Fibryga is administered intravenously, typically under the supervision of a healthcare professional. The dosage and administration schedule should be determined by a medical expert based on individual patient needs.

Common side effects of Fibryga may include allergic reactions, such as rash or itching, and thrombotic events. Patients should monitor for any adverse reactions and report them to their healthcare provider.

Yes, Fibryga can be used during surgery to prevent excessive blood loss in patients with fibrinogen deficiency. The administration should be carefully managed by a healthcare professional.

Fibryga should be used with caution in patients with a history of allergic reactions to fibrinogen or any of its components. It is important to consult with a healthcare provider to determine if Fibryga is appropriate for individual patient needs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Fibrinogen

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT